FI932284A - Kalciumkanaler blockerande polypeptider som haerstammar fraon filistata hibernalis - Google Patents

Kalciumkanaler blockerande polypeptider som haerstammar fraon filistata hibernalis Download PDF

Info

Publication number
FI932284A
FI932284A FI932284A FI932284A FI932284A FI 932284 A FI932284 A FI 932284A FI 932284 A FI932284 A FI 932284A FI 932284 A FI932284 A FI 932284A FI 932284 A FI932284 A FI 932284A
Authority
FI
Finland
Prior art keywords
calcium channel
haerstammar
blockerande
polypeptider
fraon
Prior art date
Application number
FI932284A
Other languages
English (en)
Other versions
FI932284A0 (fi
Inventor
Steven D Heck
Deane M Ii Nason
Robert T Ronau
Nicholas A Saccomano
Robert A Volkmann
Original Assignee
Pfizer
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Nps Pharma Inc filed Critical Pfizer
Publication of FI932284A0 publication Critical patent/FI932284A0/fi
Publication of FI932284A publication Critical patent/FI932284A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI932284A 1992-05-21 1993-05-19 Kalciumkanaler blockerande polypeptider som haerstammar fraon filistata hibernalis FI932284A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88707392A 1992-05-21 1992-05-21

Publications (2)

Publication Number Publication Date
FI932284A0 FI932284A0 (fi) 1993-05-19
FI932284A true FI932284A (fi) 1993-11-22

Family

ID=25390404

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932284A FI932284A (fi) 1992-05-21 1993-05-19 Kalciumkanaler blockerande polypeptider som haerstammar fraon filistata hibernalis

Country Status (26)

Country Link
US (1) US5804554A (fi)
EP (1) EP0672056B1 (fi)
JP (1) JP2572715B2 (fi)
KR (1) KR950701647A (fi)
CN (1) CN1034123C (fi)
AT (1) ATE155488T1 (fi)
AU (1) AU668170B2 (fi)
BR (1) BR9306388A (fi)
CA (1) CA2134889C (fi)
CZ (1) CZ284794A3 (fi)
DE (1) DE69312320T2 (fi)
DK (1) DK0672056T3 (fi)
EG (1) EG20275A (fi)
ES (1) ES2105261T3 (fi)
FI (1) FI932284A (fi)
GR (1) GR3024690T3 (fi)
HU (1) HUT64570A (fi)
IL (1) IL105694A (fi)
MX (1) MX9302925A (fi)
MY (1) MY108890A (fi)
NO (1) NO944417L (fi)
NZ (1) NZ252452A (fi)
RU (1) RU2106358C1 (fi)
TW (1) TW336938B (fi)
WO (1) WO1993023428A1 (fi)
ZA (1) ZA933493B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461032A (en) * 1991-03-01 1995-10-24 Fmc Corporation Insecticidally effective peptides
IL104419A0 (en) * 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
US5457178A (en) * 1993-07-07 1995-10-10 Fmc Corporation Insecticidally effective spider toxin
US5756459A (en) * 1995-06-07 1998-05-26 Fmc Corporation Insecticidally effective peptides isolatable from phidippus spider venom
CO5180581A1 (es) * 1999-09-30 2002-07-30 Pfizer Prod Inc Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239059A (en) * 1991-05-10 1993-08-24 The Children's Hospital Of Philadelphia Ion-channel forming peptides

Also Published As

Publication number Publication date
DE69312320T2 (de) 1997-10-30
EG20275A (en) 1998-05-31
CZ284794A3 (en) 1995-08-16
RU94046023A (ru) 1996-10-10
AU668170B2 (en) 1996-04-26
NO944417D0 (no) 1994-11-18
ZA933493B (en) 1994-11-21
RU2106358C1 (ru) 1998-03-10
CN1080931A (zh) 1994-01-19
DK0672056T3 (da) 1997-12-08
NZ252452A (en) 1996-07-26
EP0672056B1 (en) 1997-07-16
CN1034123C (zh) 1997-02-26
JPH07503735A (ja) 1995-04-20
JP2572715B2 (ja) 1997-01-16
IL105694A0 (en) 1993-09-22
WO1993023428A1 (en) 1993-11-25
US5804554A (en) 1998-09-08
GR3024690T3 (en) 1997-12-31
KR950701647A (ko) 1995-04-28
DE69312320D1 (de) 1997-08-21
HUT64570A (en) 1994-01-28
ATE155488T1 (de) 1997-08-15
FI932284A0 (fi) 1993-05-19
ES2105261T3 (es) 1997-10-16
TW336938B (en) 1998-07-21
AU4117893A (en) 1993-12-13
HU9301476D0 (en) 1993-09-28
MY108890A (en) 1996-11-30
CA2134889A1 (en) 1993-11-25
MX9302925A (es) 1993-11-01
NO944417L (no) 1994-11-18
IL105694A (en) 1998-02-22
BR9306388A (pt) 1998-09-15
EP0672056A1 (en) 1995-09-20
CA2134889C (en) 1998-03-31

Similar Documents

Publication Publication Date Title
YU51593A (sh) Polipeptid iz agelenopsis aperta za blokadu kanala kalcijuma
FI932284A (fi) Kalciumkanaler blockerande polypeptider som haerstammar fraon filistata hibernalis
DK0668872T3 (da) Calciumkanalblokerende polypeptider fra Theraphosidaeaphonopelma
CA2146367A1 (en) Calcium channel blocking polypeptides from heteropoda venatoria

Legal Events

Date Code Title Description
FD Application lapsed